Drakos E - Search Results

1

c-FLIP confers resistance to FAS-mediated apoptosis in anaplastic large-cell lymphoma.

Oyarzo MP, Medeiros LJ, Atwell C, Feretzaki M, Leventaki V, Drakos E, Amin HM, Rassidakis GZ. Oyarzo MP, et al. Among authors: drakos e. Blood. 2006 Mar 15;107(6):2544-7. doi: 10.1182/blood-2005-06-2601. Epub 2005 Nov 22. Blood. 2006. PMID: 16304056 Free article.

2

Caspase-3 activation in systemic anaplastic large-cell lymphoma.

Drakos E, Rassidakis GZ, Lai R, Herling M, O'Connor SL, Schmitt-Graeff A, McDonnell TJ, Medeiros LJ. Drakos E, et al. Mod Pathol. 2004 Jan;17(1):109-16. doi: 10.1038/modpathol.3800039. Mod Pathol. 2004. PMID: 14657946 Free article.

3

Differential expression of WT1 gene product in non-Hodgkin lymphomas.

Drakos E, Rassidakis GZ, Tsioli P, Lai R, Jones D, Medeiros LJ. Drakos E, et al. Appl Immunohistochem Mol Morphol. 2005 Jun;13(2):132-7. doi: 10.1097/01.pai.0000143786.62974.66. Appl Immunohistochem Mol Morphol. 2005. PMID: 15894924

4

Intrinsic apoptotic pathway in anaplastic large cell lymphoma.

Oyarzo MP, Drakos E, Atwell C, Amin HM, Medeiros LJ, Rassidakis GZ. Oyarzo MP, et al. Among authors: drakos e. Hum Pathol. 2006 Jul;37(7):874-82. doi: 10.1016/j.humpath.2006.02.020. Epub 2006 May 26. Hum Pathol. 2006. PMID: 16784988

5

Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.

Peponi E, Drakos E, Reyes G, Leventaki V, Rassidakis GZ, Medeiros LJ. Peponi E, et al. Among authors: drakos e. Am J Pathol. 2006 Dec;169(6):2171-80. doi: 10.2353/ajpath.2006.051078. Am J Pathol. 2006. PMID: 17148679 Free PMC article.

6

Differential expression of the human MIXL1 gene product in non-Hodgkin and Hodgkin lymphomas.

Drakos E, Rassidakis GZ, Leventaki V, Guo W, Medeiros LJ, Nagarajan L. Drakos E, et al. Hum Pathol. 2007 Mar;38(3):500-7. doi: 10.1016/j.humpath.2006.09.020. Hum Pathol. 2007. PMID: 17303500

7

c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders.

Drakos E, Leventaki V, Schlette EJ, Jones D, Lin P, Medeiros LJ, Rassidakis GZ. Drakos E, et al. Am J Surg Pathol. 2007 Mar;31(3):447-53. doi: 10.1097/01.pas.0000213412.25935.e4. Am J Surg Pathol. 2007. PMID: 17325487

8

NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma.

Leventaki V, Drakos E, Medeiros LJ, Lim MS, Elenitoba-Johnson KS, Claret FX, Rassidakis GZ. Leventaki V, et al. Among authors: drakos e. Blood. 2007 Sep 1;110(5):1621-30. doi: 10.1182/blood-2006-11-059451. Epub 2007 Apr 6. Blood. 2007. PMID: 17416736 Free article.

9

Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma.

Drakos E, Thomaides A, Medeiros LJ, Li J, Leventaki V, Konopleva M, Andreeff M, Rassidakis GZ. Drakos E, et al. Clin Cancer Res. 2007 Jun 1;13(11):3380-7. doi: 10.1158/1078-0432.CCR-06-2581. Clin Cancer Res. 2007. PMID: 17545546

10

Mammalian target of rapamycin (mTOR) pathway signalling in lymphomas.

Drakos E, Rassidakis GZ, Medeiros LJ. Drakos E, et al. Expert Rev Mol Med. 2008 Feb 4;10:e4. doi: 10.1017/S1462399408000586. Expert Rev Mol Med. 2008. PMID: 18241520 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters